Universe Pharmaceuticals’ (UPC) Sell (E+) Rating Reiterated at Weiss Ratings

Weiss Ratings reissued their sell (e+) rating on shares of Universe Pharmaceuticals (NASDAQ:UPC) in a research report released on Wednesday morning,Weiss Ratings reports.

Universe Pharmaceuticals Trading Down 7.1%

Shares of NASDAQ UPC opened at $6.71 on Wednesday. The firm’s 50-day moving average is $4.16. Universe Pharmaceuticals has a 1-year low of $2.51 and a 1-year high of $600.00. The company has a current ratio of 2.78, a quick ratio of 2.62 and a debt-to-equity ratio of 0.04.

About Universe Pharmaceuticals

Universe Pharmaceuticals INC, a pharmaceutical company, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications.